Mary E. Lame

843 total citations
14 papers, 511 citations indexed

About

Mary E. Lame is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Mary E. Lame has authored 14 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Pharmacology and 3 papers in Oncology. Recurrent topics in Mary E. Lame's work include Pharmacogenetics and Drug Metabolism (4 papers), Metabolomics and Mass Spectrometry Studies (3 papers) and Alzheimer's disease research and treatments (3 papers). Mary E. Lame is often cited by papers focused on Pharmacogenetics and Drug Metabolism (4 papers), Metabolomics and Mass Spectrometry Studies (3 papers) and Alzheimer's disease research and treatments (3 papers). Mary E. Lame collaborates with scholars based in United States, United Kingdom and Sweden. Mary E. Lame's co-authors include Erin Chambers, Amit S. Kalgutkar, Matthew Blatnik, John R. Soglia, Scott Peterman, Kirk R. Henne, Sabrina X. Zhao, Steven M. Finegan, Michael W. Dunne and D Girard and has published in prestigious journals such as Analytical Biochemistry, Journal of Antimicrobial Chemotherapy and Drug Metabolism and Disposition.

In The Last Decade

Mary E. Lame

13 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mary E. Lame United States	10	224	138	137	108	61	14	511
Staffan Schmidt Sweden	11	152 0.7×	129 0.9×	53 0.4×	175 1.6×	32 0.5×	23	656
James E. Grace United States	13	145 0.6×	58 0.4×	152 1.1×	45 0.4×	83 1.4×	21	555
Linyee Shum United States	12	271 1.2×	82 0.6×	101 0.7×	29 0.3×	37 0.6×	23	782
Shuet‐Hing Lee Chiu United States	15	200 0.9×	101 0.7×	99 0.7×	65 0.6×	20 0.3×	29	721
Thomas N. O’Connell United States	12	367 1.6×	82 0.6×	129 0.9×	84 0.8×	111 1.8×	19	698
Louis Leung United States	16	195 0.9×	49 0.4×	287 2.1×	75 0.7×	117 1.9×	24	754
Sicheng Liang China	16	382 1.7×	88 0.6×	176 1.3×	36 0.3×	23 0.4×	53	801
Susanna Tse United States	14	146 0.7×	32 0.2×	118 0.9×	40 0.4×	37 0.6×	26	474
Suzanne L. Iverson Sweden	15	432 1.9×	244 1.8×	92 0.7×	34 0.3×	21 0.3×	16	836
William J. Leavens United Kingdom	12	233 1.0×	381 2.8×	80 0.6×	35 0.3×	33 0.5×	18	654

Countries citing papers authored by Mary E. Lame

Since Specialization

Citations

This map shows the geographic impact of Mary E. Lame's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary E. Lame with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary E. Lame more than expected).

Fields of papers citing papers by Mary E. Lame

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary E. Lame. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary E. Lame. The network helps show where Mary E. Lame may publish in the future.

Co-authorship network of co-authors of Mary E. Lame

This figure shows the co-authorship network connecting the top 25 collaborators of Mary E. Lame. A scholar is included among the top collaborators of Mary E. Lame based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary E. Lame. Mary E. Lame is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Lame, Mary E., et al.. (2019). Development of an UPLC/MS–MS Method for Quantification of Intact IGF-I from Human Serum. Bioanalysis. 12(1). 53–65. 15 indexed citations

Pannee, Josef, Johan Gobom, Leslie M. Shaw, et al.. (2015). Round robin test on quantification of amyloid‐β 1–42 in cerebrospinal fluid by mass spectrometry. Alzheimer s & Dementia. 12(1). 55–59. 41 indexed citations

Chambers, Erin, Mary E. Lame, Paul Rainville, et al.. (2015). Practical Applications of Integrated Microfluidics for Peptide Quantification. Bioanalysis. 7(7). 857–867. 10 indexed citations

Lame, Mary E., et al.. (2014). SPE-LC–MS/MS method for the quantification of Bradykinin in human plasma. Clinical Biochemistry. 47(12). 1158–1158. 1 indexed citations

Chambers, Erin, Mary E. Lame, Cristina Legido‐Quigley, et al.. (2013). High sensitivity LC–MS/MS method for direct quantification of human parathyroid 1–34 (teriparatide) in human plasma. Journal of Chromatography B. 938. 96–104. 24 indexed citations

Lame, Mary E., Erin Chambers, & Matthew Blatnik. (2011). Quantitation of amyloid beta peptides Aβ1–38, Aβ1–40, and Aβ1–42 in human cerebrospinal fluid by ultra-performance liquid chromatography–tandem mass spectrometry. Analytical Biochemistry. 419(2). 133–139. 95 indexed citations

Chambers, Erin, et al.. (2010). ANALYTICAL CHALLENGES IN THE DEVELOPMENT OF A QUANTITATIVE SPE/LC/MS/MS ASSAY FOR AMYLOID BETA PEPTIDES IN CEREBROSPINAL FLUID. Medical Entomology and Zoology. 25. 240–240. 1 indexed citations

Conboy, James J., et al.. (2008). Modification of amyloid-β(1–40) by a protease inhibitor creates risk of error in mass spectrometric quantitation of amyloid-β(1–42). Analytical Biochemistry. 382(2). 147–149. 4 indexed citations

Kalgutkar, Amit S., Deepak Dalvie, Jiri Aubrecht, et al.. (2007). Genotoxicity of 2-(3-Chlorobenzyloxy)-6-(piperazinyl)pyrazine, a Novel 5-Hydroxytryptamine2c Receptor Agonist for the Treatment of Obesity: Role of Metabolic Activation. Drug Metabolism and Disposition. 35(6). 848–858. 36 indexed citations

10.

Peterman, Scott, et al.. (2006). Application of a linear ion trap/orbitrap mass spectrometer in metabolite characterization studies: Examination of the human liver microsomal metabolism of the non-tricyclic anti-depressant nefazodone using data-dependent accurate mass measurements. Journal of the American Society for Mass Spectrometry. 17(3). 363–375. 83 indexed citations

11.

Girard, D, Steven M. Finegan, Michael W. Dunne, & Mary E. Lame. (2005). Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models. Journal of Antimicrobial Chemotherapy. 56(2). 365–371. 57 indexed citations

12.

Kalgutkar, Amit S., Kirk R. Henne, Mary E. Lame, et al.. (2005). Metabolic activation of the nontricyclic antidepressant trazodone to electrophilic quinone-imine and epoxide intermediates in human liver microsomes and recombinant P4503A4. Chemico-Biological Interactions. 155(1-2). 10–20. 38 indexed citations

13.

Kalgutkar, Amit S., Alfin D. N. Vaz, Mary E. Lame, et al.. (2004). BIOACTIVATION OF THE NONTRICYCLIC ANTIDEPRESSANT NEFAZODONE TO A REACTIVE QUINONE-IMINE SPECIES IN HUMAN LIVER MICROSOMES AND RECOMBINANT CYTOCHROME P450 3A4. Drug Metabolism and Disposition. 33(2). 243–253. 102 indexed citations

14.

Lame, Mary E., Amit S. Kalgutkar, & Michael LaFontaine. (2004). Intravenous Pharmacokinetics and Metabolism of the Reactive Oxygen Scavenger α-Phenyl-N-Tert-Butyl Nitrone (PBN) in the Cynomolgus Monkey. Drug metabolism and drug interactions. 20(1-2). 11–24. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact